Additionally, ATR deletion from a smoothened overexpressing SHH model through cre-recombination (SmoM2;AtrG-cre), inhibits tumor formation; all of which suggest a requirement for ATR in maintaining genomic stability during cerebellar development and tumor formation, nominating the ATR-Chk1 axis as a potential therapeutic target. This evidence concerns the gene CHEK1 and neoplasm.